Published in J Nutr Educ Behav on April 19, 2013
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
The global obesity pandemic: shaped by global drivers and local environments. Lancet (2011) 13.23
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Changing the future of obesity: science, policy, and action. Lancet (2011) 5.56
Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52
Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67
Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med (2005) 3.38
Activation of the peripheral endocannabinoid system in human obesity. Diabetes (2005) 2.90
Weight loss and the renin-angiotensin-aldosterone system. Hypertension (2005) 2.58
Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Ann Intern Med (2012) 2.52
A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg (2010) 2.41
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS (2007) 2.39
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Periadventitial fat releases a vascular relaxing factor. FASEB J (2002) 2.29
Retinol-binding protein 4 in human obesity. Diabetes (2006) 2.17
Association between adiponectin and mediators of inflammation in obese women. Diabetes (2003) 2.05
Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis (2010) 1.95
Antipsychotics for children and young adults: a comparative effectiveness review. Pediatrics (2012) 1.93
Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res (2004) 1.91
The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. J Lipid Res (2009) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res (2002) 1.86
Systematic review of knowledge translation strategies in the allied health professions. Implement Sci (2012) 1.81
Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens (2002) 1.79
Clinical review: modified 5 As: minimal intervention for obesity counseling in primary care. Can Fam Physician (2013) 1.76
Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes (2002) 1.70
Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ (2011) 1.70
Reporting weight loss: is simple better? Obesity (Silver Spring) (2010) 1.67
Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care (2010) 1.66
The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation. J Hypertens (2002) 1.65
The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol (2003) 1.65
Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: two-year prospective cohort study. BMC Med (2014) 1.61
Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab (2011) 1.58
Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) (2008) 1.56
Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) (2008) 1.54
Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res (2006) 1.53
Complications associated with adjustable gastric banding for morbid obesity: a surgeon's guides. Can J Surg (2011) 1.52
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis. J Hypertens (2003) 1.51
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens (2004) 1.48
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH. Eur Heart J (2009) 1.48
Quality of life and psychosocial health in postmenopausal women achieving public health guidelines for physical activity. Menopause (2010) 1.46
Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med (2011) 1.45
Barriers to obesity treatment. Eur J Intern Med (2007) 1.43
Role of CYP2C9 genetic variants for salt sensitivity and the regulation of the renin-angiotensin-aldosterone system in normotensive men. J Hypertens (2011) 1.42
Association of hypoglycemic treatment regimens with cardiovascular outcomes in overweight and obese subjects with type 2 diabetes: a substudy of the SCOUT trial. Diabetes Care (2013) 1.41
The management of hypertension in the overweight and obese patient: is weight reduction sufficient? Drugs (2004) 1.39
Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE). PLoS One (2011) 1.38
Medical tourism in bariatric surgery. Am J Surg (2010) 1.36
beta-cell neogenesis during prolonged hyperglycemia in rats. Diabetes (2002) 1.33
Weight recidivism post-bariatric surgery: a systematic review. Obes Surg (2013) 1.33
Treating severe obesity: morbid weights and morbid waits. CMAJ (2009) 1.25
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol (2011) 1.24
Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review. Surg Obes Relat Dis (2010) 1.23
Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg (2005) 1.22
A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun (2006) 1.22
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20
Adipose tissue metabolism and CD11b expression on monocytes in obese hypertensives. Hypertension (2005) 1.19
Neighborhood physical activity opportunities for inner-city children and youth. Health Place (2009) 1.15
Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des (2007) 1.14
Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol (2007) 1.12
Water-induced thermogenesis. J Clin Endocrinol Metab (2003) 1.11
Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation (2002) 1.11
Obesity research in Canada: literature overview of the last 3 decades. Obes Res (2004) 1.10
Metabolic profile and exercise capacity outcomes: their relationship to overweight and obesity in a Canadian cardiac rehabilitation setting. J Cardiopulm Rehabil (2005) 1.09
Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation. J Hypertens (2006) 1.08
Adolescent athletes: psychosocial challenges and clinical concerns. Curr Opin Psychiatry (2012) 1.07
Development and multi-site validation of a new condition-specific quality of life measure for eating disorders. Health Qual Life Outcomes (2007) 1.07
Becoming a "treatment success": what helps and what hinders patients from achieving and sustaining undetectable viral loads. AIDS Patient Care STDS (2006) 1.06
Managing complications associated with laparoscopic Roux-en-Y gastric bypass for morbid obesity. Can J Surg (2012) 1.06
Serum- and glucocorticoid-regulated kinase (SGK1) gene and blood pressure. Hypertension (2002) 1.05
New pharmacological approaches for obesity management. Nat Rev Endocrinol (2013) 1.04
Systems science and obesity policy: a novel framework for analyzing and rethinking population-level planning. Am J Public Health (2014) 1.03
Characteristics of the population eligible for and receiving publicly funded bariatric surgery in Canada. Int J Equity Health (2012) 1.03
The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res (2010) 1.03
Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol (2010) 1.02
Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. Am J Physiol Endocrinol Metab (2007) 1.02
Regulation of the nitric oxide system in human adipose tissue. J Lipid Res (2004) 1.02
Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation (2003) 1.01
Getting from analysis to action: framing obesity research, policy and practice with a solution-oriented complex systems lens. Healthc Pap (2008) 1.01
Do cardiac and perivascular adipose tissue play a role in atherosclerosis? Curr Diab Rep (2008) 1.00
A case study of physical activity among older adults in rural Newfoundland, Canada. J Aging Phys Act (2007) 0.99
A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice. J Appl Physiol (1985) (2007) 0.98
Reluctance to recover in anorexia nervosa. Eur Eat Disord Rev (2011) 0.98
Uptake and effectiveness of the Children's Fitness Tax Credit in Canada: the rich get richer. BMC Public Health (2010) 0.98
Laparoscopic sleeve gastrectomy: an innovative new tool in the battle against the obesity epidemic in Canada. Can J Surg (2010) 0.98
Cross-sector partnerships and public health: challenges and opportunities for addressing obesity and noncommunicable diseases through engagement with the private sector. Annu Rev Public Health (2015) 0.97
Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals. PLoS One (2013) 0.97
Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. Metabolism (2009) 0.97
The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev (2011) 0.96
Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res (2012) 0.96
Glycemic index predicts individual glucose responses after self-selected breakfasts in free-living, abdominally obese adults. J Nutr (2011) 0.96
Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol (2011) 0.96
Baroreflex buffering and susceptibility to vasoactive drugs. Circulation (2002) 0.94
Implementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial. Implement Sci (2014) 0.94
Health status, quality of life, and satisfaction of patients awaiting multidisciplinary bariatric care. BMC Health Serv Res (2012) 0.94
Awareness of Canada's Physical Activity Guide to Healthy Active Living in a large community sample. Am J Health Promot (2011) 0.93